Clinical considerations: Anticoagulation use in older adults
Anticoagulation therapy in older adults requires careful consideration due to age-related changes in
physiology, increased risk of comorbidities, and higher susceptibility to adverse drug reactions. This
resource highlights facts and clinical considerations related to use of anticoagulants in older adults.
Download now
Show You Know: Anticoagulation in the older adult
Current evidence indicates that 20% to 50% of direct oral anticoagulant doses are inappropriate in older
adults. Over- and underdosing of anticoagulants in the older adult population can lead to adverse
effects and increased risk of stroke, systemic embolism, and cardiovascular hospitalizations. Take this
short quiz to assess your skill related to best practices of use of anticoagulants in older adults.
Take the quiz
The Journey to Atrial Fibrillation Management: A Patient Perspective
Atrial fibrillation is the most common type of irregular heartbeat, affecting more than 5 million adults
in the United States and it is estimated that 12.1 million people in the United States will experience
atrial fibrillation in 2030.Atrial fibrillation is the most common type of irregular heartbeat,
affecting more than 5 million adults in the United States and it is estimated that 12.1 million people
in the United States will develop atrial fibrillation in 2030. This course includes 3 modules that
features a patient's perspective during their journey with atrial fibrillation. Supported by an
educational grant from Bristol-Myers Squibb-Pfizer Alliance.
Access
the course
Solutions for Atrial Fibrillation Edvocacy (SAFE) - APhA Foundation
Solutions for Atrial Fibrillation Edvocacy (SAFE) was a research project focused
on leveraging community pharmacies for Afib screening, detection, and referral
to physicians for follow-up and initiation of evidence-based therapy when
appropriate. This prospective research study was conducted with 14
community pharmacies across the US, in which a total of 650 patients were
screened for Afib. Pharmacists conducted SAFEty Risk Assessments that
consisted of completion of a Stroke Risk Scorecard and EKG determination
utilizing AliveCor’s KardiaMobile® 6L device.
Download now